Oxford Immunotec Global PLC Ordinary Shares
OXFD
OXFD was delisted on the 5th of March, 2021.
73 hedge funds and large institutions have $411M invested in Oxford Immunotec Global PLC Ordinary Shares in 2019 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 26 increasing their positions, 27 reducing their positions, and 24 closing their positions.
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
19% more capital invested
Capital invested by funds: $346M → $411M (+$65.4M)
4% less repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 27
15% less funds holding
Funds holding: 86 → 73 (-13)
50% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 24
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Man Group
London,
United Kingdom
|
+$10.2M |
| 2 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$8.01M |
| 3 |
SAM
Silvercrest Asset Management
New York
|
+$6.41M |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$6.28M |
| 5 |
ECM
Endurant Capital Management
San Mateo,
California
|
+$4.98M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
-$24.7M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$4.65M |
| 3 |
Morgan Stanley
New York
|
-$3.9M |
| 4 |
CCM
Consonance Capital Management
New York
|
-$2.75M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$2.52M |
OXFD Hedge Fund Activity: Q3 2019 in Review
73 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Oxford Immunotec Global PLC Ordinary Shares (OXFD) for Q3 2019, worth a combined $411M — up 19% from $346M a quarter earlier.
Sellers outnumbered buyers: 24 funds closed out of OXFD and 12 opened new positions — a net loss of 12 holders — while 27 trimmed existing stakes and 26 added.
The largest buyer was Man Group, opening a new position worth an estimated $10.2M. The largest seller was Redmile Group, exiting entirely with an estimated $24.7M sold.
- 73 institutional investors held Oxford Immunotec Global PLC Ordinary Shares (OXFD) as of Q3 2019, down from 86 in Q2 2019.
- Funds reported $411M of Oxford Immunotec Global PLC Ordinary Shares stock for Q3 2019, up 19% quarter-over-quarter.
- 12 funds opened new Oxford Immunotec Global PLC Ordinary Shares positions in Q3 2019 and 24 closed out, a net change of -12 holders.
- The largest Oxford Immunotec Global PLC Ordinary Shares buyer in Q3 2019 was Man Group, an estimated $10.2M added.
- The largest Oxford Immunotec Global PLC Ordinary Shares seller in Q3 2019 was Redmile Group, an estimated $24.7M sold.
Based on aggregated 13F filings for Q3 2019.